Papers
2
Total Citations
6
H-Index
2
About
Dr. Dingwei Ye is a leading figure in urologic oncology, with a primary research focus on bladder cancer surgical outcomes and the advancement of robotic-assisted urologic procedures. His major contributions center on large-scale, multicenter comparative effectiveness research, most notably through his work with the Chinese Bladder Cancer Consortium. His highly cited 2020 study, "Survival after radical cystectomy for bladder cancer," provided critical real-world evidence comparing oncological outcomes between minimally invasive and open surgical approaches, directly informing clinical decision-making for thousands of patients. With over 4 citations, this work has shaped international guidelines on cystectomy techniques. More recently, Dr. Ye has been at the forefront of surgical innovation, authoring a 2025 paper on new robotic surgical platforms in China and their applications in urologic surgeries, highlighting his role in integrating cutting-edge technology into clinical practice. His research bridges the gap between surgical innovation and evidence-based outcomes, making him a key opinion leader in the field. Dr. Ye’s work continues to influence how urologic cancers are treated, emphasizing safety, efficacy, and the future of minimally invasive surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2